Načítá se...
Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?
BACKGROUND/AIM: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: Ninety-seven patients with type 2 diabetes admitted to...
Uloženo v:
| Vydáno v: | Turk J Med Sci |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Scientific and Technological Research Council of Turkey
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8203126/ https://ncbi.nlm.nih.gov/pubmed/33356033 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-2008-37 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|